Beacon Topco Q3 2026 Results: Net Loss of $6.1M, Loss Narrows
For the nine months ended September 30, 2026, Beacon Topco reported a net loss of $22.2 million, a significant reduction from the $55.4 million loss in the prior year period. The company maintained a cash position of $49.2 million and plans to rename itself Clywedog Therapeutics Holdings, Inc. following a pending merger transaction.
- Key figure
- Net loss $6.1M